BioSpace News Archive

InxMed announced the first-in-class ADC OMTX705 has obtained the IND approval from China National Medical Products Administration recently.

Theralase® Technologies Inc., a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds, their associated drug formulations and the light systems that activate them, intended to safely and effectively destroy various cancers has released the Company’s 2Q2023 unaudited condensed interim consolidated Financial Statements.

10x Genomics, Inc., a leader in single cell and spatial biology, announced that it has shipped more than 100 Xenium Analyzer instruments in the eight months since the platform’s launch.

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”) is pleased to provide an update on the planned launch of the TeloView®SMM (Smoldering Multiple Myeloma) assay in the fourth quarter of this year.

Epigenic Therapeutics today announced that it has raised $32 million in Series A round of financing co-led by Qiming Venture Partners and OrbiMed, with participation from existing investor Morningside Venture Capital.

Shanghai Fosun Pharmaceutical Co., Ltd.* announced its 2023 Interim Results for the first half of 2023.

Mindray, a global leader in providing advanced medical device solutions, has unveiled upgrades to its A7 and A5 anaesthesia systems under the A Series Anaesthesia.

Tango Therapeutics, Inc., a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, announced changes to its Board of Directors.

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its second quarter 2023 financial results.

AIDS Healthcare Foundation commended President Joseph Biden on his administration’s efforts to control drug pricing by compelling pharmaceutical companies choosing to participate in Medicare to engage in drug price negotiations.